301 related articles for article (PubMed ID: 25263451)
21. Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases.
Wang Y; Hu J; Wu S; Fleishman JS; Li Y; Xu Y; Zou W; Wang J; Feng Y; Chen J; Wang H
Signal Transduct Target Ther; 2023 Dec; 8(1):449. PubMed ID: 38072908
[TBL] [Abstract][Full Text] [Related]
22. Covalent Modifications of RUNX Proteins: Structure Affects Function.
Blumenthal E; Greenblatt S; Huang G; Ando K; Xu Y; Nimer SD
Adv Exp Med Biol; 2017; 962():33-44. PubMed ID: 28299649
[TBL] [Abstract][Full Text] [Related]
23. RUNX1-dependent mechanisms in biological control and dysregulation in cancer.
Hong D; Fritz AJ; Gordon JA; Tye CE; Boyd JR; Tracy KM; Frietze SE; Carr FE; Nickerson JA; Van Wijnen AJ; Imbalzano AN; Zaidi SK; Lian JB; Stein JL; Stein GS
J Cell Physiol; 2019 Jun; 234(6):8597-8609. PubMed ID: 30515788
[TBL] [Abstract][Full Text] [Related]
24. Blood malignancies presenting with mutations at equivalent residues in RUNX1-2 suggest a common leukemogenic pathway.
Callea M; Fattori F; Bertini ES; Cammarata-Scalisi F; Callea F; Bellacchio E
Leuk Lymphoma; 2017 Aug; 58(8):2002-2004. PubMed ID: 28093006
[No Abstract] [Full Text] [Related]
25. The enigmatic role of RUNX1 in female-related cancers - current knowledge & future perspectives.
Riggio AI; Blyth K
FEBS J; 2017 Aug; 284(15):2345-2362. PubMed ID: 28304148
[TBL] [Abstract][Full Text] [Related]
26. Phosphorylation of Runx1 at Ser249, Ser266, and Ser276 is dispensable for bone marrow hematopoiesis and thymocyte differentiation.
Tachibana M; Tezuka C; Muroi S; Nishimoto S; Katsumoto T; Nakajima A; Kitabayashi I; Taniuchi I
Biochem Biophys Res Commun; 2008 Apr; 368(3):536-42. PubMed ID: 18261462
[TBL] [Abstract][Full Text] [Related]
27. The long non-coding RNA H19-derived miR-675 modulates human gastric cancer cell proliferation by targeting tumor suppressor RUNX1.
Zhuang M; Gao W; Xu J; Wang P; Shu Y
Biochem Biophys Res Commun; 2014 Jun; 448(3):315-22. PubMed ID: 24388988
[TBL] [Abstract][Full Text] [Related]
28. RUNX1 and its understudied role in breast cancer.
Janes KA
Cell Cycle; 2011 Oct; 10(20):3461-5. PubMed ID: 22024923
[TBL] [Abstract][Full Text] [Related]
29. RUNX1 meets MLL: epigenetic regulation of hematopoiesis by two leukemia genes.
Koh CP; Wang CQ; Ng CE; Ito Y; Araki M; Tergaonkar V; Huang G; Osato M
Leukemia; 2013 Sep; 27(9):1793-802. PubMed ID: 23817177
[TBL] [Abstract][Full Text] [Related]
30. Multiple post-translational modifications in hepatocyte nuclear factor 4α.
Yokoyama A; Katsura S; Ito R; Hashiba W; Sekine H; Fujiki R; Kato S
Biochem Biophys Res Commun; 2011 Jul; 410(4):749-53. PubMed ID: 21708125
[TBL] [Abstract][Full Text] [Related]
31. The role of Runx1/AML1 and Evi-1 in the regulation of hematopoietic stem cells.
Kumano K; Kurokawa M
J Cell Physiol; 2010 Feb; 222(2):282-5. PubMed ID: 19847803
[TBL] [Abstract][Full Text] [Related]
32. RUNX transcription factors at the interface of stem cells and cancer.
Deltcheva E; Nimmo R
Biochem J; 2017 May; 474(11):1755-1768. PubMed ID: 28490659
[TBL] [Abstract][Full Text] [Related]
33. Targeting post-translational modifications of histones for cancer therapy.
Hsu YC; Hsieh YH; Liao CC; Chong LW; Lee CY; Yu YL; Chou RH
Cell Mol Biol (Noisy-le-grand); 2015 Oct; 61(6):69-84. PubMed ID: 26518898
[TBL] [Abstract][Full Text] [Related]
34. Normal and transforming functions of RUNX1: a perspective.
Mikhail FM; Sinha KK; Saunthararajah Y; Nucifora G
J Cell Physiol; 2006 Jun; 207(3):582-93. PubMed ID: 16250015
[TBL] [Abstract][Full Text] [Related]
35. Cdk6 blocks myeloid differentiation by interfering with Runx1 DNA binding and Runx1-C/EBPalpha interaction.
Fujimoto T; Anderson K; Jacobsen SE; Nishikawa SI; Nerlov C
EMBO J; 2007 May; 26(9):2361-70. PubMed ID: 17431401
[TBL] [Abstract][Full Text] [Related]
36. Core binding factor genes and human leukemia.
Hart SM; Foroni L
Haematologica; 2002 Dec; 87(12):1307-23. PubMed ID: 12495904
[TBL] [Abstract][Full Text] [Related]
37. Developmentally regulated promoter-switch transcriptionally controls Runx1 function during embryonic hematopoiesis.
Pozner A; Lotem J; Xiao C; Goldenberg D; Brenner O; Negreanu V; Levanon D; Groner Y
BMC Dev Biol; 2007 Jul; 7():84. PubMed ID: 17626615
[TBL] [Abstract][Full Text] [Related]
38. RUNX1 suppression induces megakaryocytic differentiation of UT-7/GM cells.
Nagai R; Matsuura E; Hoshika Y; Nakata E; Nagura H; Watanabe A; Komatsu N; Okada Y; Doi T
Biochem Biophys Res Commun; 2006 Jun; 345(1):78-84. PubMed ID: 16674921
[TBL] [Abstract][Full Text] [Related]
39. Helicase-like transcription factor is a RUNX1 target whose downregulation promotes genomic instability and correlates with complex cytogenetic features in acute myeloid leukemia.
Cheng CK; Chan NP; Wan TS; Lam LY; Cheung CH; Wong TH; Ip RK; Wong RS; Ng MH
Haematologica; 2016 Apr; 101(4):448-57. PubMed ID: 26802049
[TBL] [Abstract][Full Text] [Related]
40. Proleukemic RUNX1 and CBFbeta mutations in the pathogenesis of acute leukemia.
Engel ME; Hiebert SW
Cancer Treat Res; 2010; 145():127-47. PubMed ID: 20306249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
